Bionano Genomics is a medical instruments & supplies business based in the US. Bionano Genomics shares (BNGO) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.38 – an increase of 0.9% over the previous week. Bionano Genomics employs 98 staff and has a trailing 12-month revenue of around $28.5 million.
Terms and conditions apply*. For 401k rollovers, existing SoFi IRA members must complete 401k rollovers via this link For SoFi members without a SoFi IRA, a SoFi IRA must first be opened, and 401k rollover must be completed utilizing Capitalize via this link. SoFi and Capitalize will charge no additional fees to process a 401(k) rollover to a SoFi IRA. SoFi is not liable for any costs incurred from the existing 401k provider for rollover. Please check with your 401k provider for any fees or costs associated with the rollover. For IRA contributions, only deposits made via ACH and cash transfer from SoFi Bank accounts are eligible for the match. Click here for the 1% Match terms and conditions.
Must be a SoFi Plus member at the time a recurring deposit is received into your SoFi Active or Automated investing account to qualify. Bonus calculated on net monthly recurring deposits made via ACH and paid out as Rewards Points. See Rewards Terms of Service. SoFi reserves the right to change or terminate this promotion at any time without notice. See terms and limitations. https://www.sofi.com/sofiplus/invest/#disclaimers
Open an account.Provide your personal information and sign up.
Fund your account.Deposit funds into your account by linking your banking information or transfer funds from another trading account.
Search for the stock name – BNGO.Search for the stock by name or ticker symbol.
Buy the stock. Place your order. It's that simple.
Buy Bionano Genomics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.
7 of 7
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Bionano Genomics stock price (NASDAQ: BNGO)
Use our graph to track the performance of BNGO stocks over time.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Bionano Genomics price performance over time
Historical closes compared with the close of $3.38 from 2025-07-15
1 week (2025-07-09)
0.90%
1 month (2025-06-17)
3.68%
3 months (2025-04-17)
-16.54%
6 months (2025-01-17)
1,647.67%
1 year (2024-07-17)
408.65%
2 years (2023-07-14)
-99.13%
3 years (2022-07-15)
924
5 years (2020-07-16)
312.0001
Bionano Genomics financials
Revenue TTM
$28.5 million
Gross profit TTM
$494,000
Return on assets TTM
-30.7%
Return on equity TTM
-127.82%
Profit margin
-294.05%
Book value
$15.54
Market Capitalization
$11.4 million
TTM: trailing 12 months
Bionano Genomics share dividends
We're not expecting Bionano Genomics to pay a dividend over the next 12 months.
Have Bionano Genomics's shares ever split?
Bionano Genomics's shares were
split on a 1:60 basis on 26 January 2025
. So if you had owned 60 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Bionano Genomics shares – just the quantity. However, indirectly, the new 5900% higher share price could have impacted the market appetite for Bionano Genomics shares which in turn could have impacted Bionano Genomics's share price.
Bionano Genomics share price volatility
Over the last 12 months, Bionano Genomics's shares have ranged in value from as little as $2.68 up to $41.1. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bionano Genomics's is 2.28. This would suggest that Bionano Genomics's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Bionano Genomics overview
Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. The company offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. It also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic data from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, the company offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.
Frequently asked questions
null What percentage of Bionano Genomics is owned by insiders or institutions? Currently 0.063% of Bionano Genomics shares are held by insiders and 9.13% by institutions.How many people work for Bionano Genomics? Latest data suggests 98 work at Bionano Genomics.When does the fiscal year end for Bionano Genomics? Bionano Genomics's fiscal year ends in December.Where is Bionano Genomics based? Bionano Genomics's address is: 9540 Towne Centre Drive, San Diego, CA, United States, 92121What is Bionano Genomics's ISIN number? Bionano Genomics's international securities identification number is: US09075F3055What is Bionano Genomics's CUSIP number? Bionano Genomics's Committee on Uniform Securities Identification Procedures number is: 09075F206
Looking to invest in AI stocks? Here are some of the best artificial intelligence stocks available, along with tips to better understand AI investments.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
